Literature DB >> 21225435

Sotos syndrome and scoliosis surgical treatment: a 10-year follow-up.

Romina Corrado1, Alejandra Francheri Wilson, Carlos Tello, Mariano Noel, Eduardo Galaretto, Ernesto Bersusky.   

Abstract

Sotos syndrome is caused by a gene deletion with an autosomal dominant pattern of inheritance. Cerebral gigantism, hypotonia and joint hyperextensibility are characteristic features of this syndrome. A percentage of these patients develop progressive scoliosis early in life. In the literature, few studies on the evolution of scoliosis in Sotos syndrome have been published. We retrospectively evaluated eight patients diagnosed with Sotos syndrome and scoliosis treated at the Garrahan Children Hospital between 1988 and March 2009. Clinical charts and imaging studies were assessed. Eight patients (19%) presented with scoliosis and seven of them (87.5%) required surgical treatment. The mean follow-up was 9.5 years (range 3-18). Mean age at first consultation was 5.2 years (range 1.1-11.2). Mean Cobb angle for scoliosis at first consultation was 34.3° (range 20°-42°) and the mean Cobb angle for kyphosis was 45.6° (range 30°-90°). Mean age at surgery was 11.2 years (range 3.7-18.10). The surgical procedures performed were instrumented posterior arthrodesis, alone or combined with anterior arthrodesis, instrumented anterior arthrodesis, while one patient is currently in treatment with growing rods. Preoperative mean Cobb angle for scoliosis was 72.3° (range 54°-130°) and for kyphosis was 59.8° (range 30°-108°); postoperative mean Cobb angle for scoliosis was 45.5° (range 6°-90°) and for kyphosis was 40.2° (range 30°-80°). There were three early complications (pleural effusion in two cases and death due to sepsis in one) and two late complications (kyphosis above the instrumentation area and dislodgement of the proximal hooks). Incidence of scoliosis in Sotos syndrome is high and thus close monitoring of patients with Sotos syndrome during growth is important for early detection of this entity. Joint hyperextensibility and hypotonia that are characteristic of the syndrome should be considered at the moment of surgery to avoid short fusions.

Entities:  

Mesh:

Year:  2011        PMID: 21225435      PMCID: PMC3111518          DOI: 10.1007/s00586-010-1685-2

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  9 in total

1.  Sotos syndrome: two cases with severe scoliosis.

Authors:  Elizabeth Sweeney; Alan Fryer; Dian Donnai
Journal:  Clin Dysmorphol       Date:  2002-04       Impact factor: 0.816

2.  CEREBRAL GIGANTISM IN CHILDHOOD. A SYNDROME OF EXCESSIVELY RAPID GROWTH AND ACROMEGALIC FEATURES AND A NONPROGRESSIVE NEUROLOGIC DISORDER.

Authors:  J F SOTOS; P R DODGE; D MUIRHEAD; J D CRAWFORD; N B TALBOT
Journal:  N Engl J Med       Date:  1964-07-16       Impact factor: 91.245

3.  Cervical instability in Sotos syndrome: a case report.

Authors:  Waldemar Carlo; John P Dormans
Journal:  Spine (Phila Pa 1976)       Date:  2004-04-01       Impact factor: 3.468

4.  Posterior spinal fusion in Sotos' syndrome.

Authors:  D Suresh
Journal:  Br J Anaesth       Date:  1991-06       Impact factor: 9.166

5.  Sotos syndrome: a study of the diagnostic criteria and natural history.

Authors:  T R Cole; H E Hughes
Journal:  J Med Genet       Date:  1994-01       Impact factor: 6.318

6.  [Sotos syndrome associated with focal dystonia].

Authors:  M Bravo; J Chacón; E Bautista; I Pérez-Camacho; A Trujillo; M A Grande
Journal:  Rev Neurol       Date:  1999 May 16-31       Impact factor: 0.870

7.  Scoliosis in cerebral gigantism, Sotos syndrome. A case report.

Authors:  N Haga; S Nakamura; M Shimode; Y Yanagisako; T Iwaya
Journal:  Spine (Phila Pa 1976)       Date:  1996-07-15       Impact factor: 3.468

8.  Spinal deformity in patients with Sotos syndrome (cerebral gigantism).

Authors:  Athanasios I Tsirikos; Nestor Demosthenous; Michael J McMaster
Journal:  J Spinal Disord Tech       Date:  2009-04

9.  Sotos syndrome.

Authors:  Katrina Tatton-Brown; Nazneen Rahman
Journal:  Eur J Hum Genet       Date:  2006-09-13       Impact factor: 4.246

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.